DRG付费下国家谈判药品政策落地的实践  

Practice of National Negotiated Drug Policy Implementation under DRG Payment

作　　者：严晶 张燕 YAN Jing;ZHANG Yan(Medical Security Bureau of Zhejiang Ningbo,Ningbo Zhejiang 315099,China)

机构地区：[1]浙江省宁波市医疗保障局,浙江宁波315099

出　　处：《卫生经济研究》2021年第12期20-21,32,共3页

摘　　要：浙江省宁波市在DRG付费下,将国家谈判药品按实际费用折算为DRG点数进行支付,以此鼓励医生使用国家谈判药品,切实降低患者经济负担。对此,结合目前实际,提出政策建议:建立国家谈判药品监测评估机制,单独考核国家谈判抗癌药品,积极推进内科日间治疗,加强对医保定点药店的监管。Under the payment of DRG,Ningbo City in Zhejiang Province converts the national negotiated drugs into DRG points based on the actual cost,so as to encourage doctors to use national negotiated drugs and effectively reduce the economic burden of patients.In this regard,in light of the current reality,policy recommendations are put forward:establish a national negotiated drug monitoring and evaluation mechanism,separately assess national negotiated on anti-cancer drugs,actively promote internal medicine day treatment,and strengthen the supervision of designated pharmacies of medical insurance.

关 键 词：国家谈判药品 DRG付费改革 患者经济负担 

分 类 号：R95[医药卫生—药学]